De Crignis E, Mahmoudi T
Department of Biochemistry, Erasmus University Medical Centre , Rotterdam , The Netherlands.
Department of Biochemistry, Erasmus University Medical Centre , Rotterdam , The Netherlands.
Int Rev Cell Mol Biol. 2017;328:197-252. doi: 10.1016/bs.ircmb.2016.08.006. Epub 2016 Oct 5.
The capacity of the human immunodeficiency virus (HIV-1) to establish latent infections constitutes a major barrier to the development of a cure for HIV-1. In latent infection, replication competent HIV-1 provirus is integrated within the host genome but remains silent, masking the infected cells from the activity of the host immune response. Despite the progress in elucidating the molecular players that regulate HIV-1 gene expression, the mechanisms driving the establishment and maintenance of latency are still not fully understood. Transcription from the HIV-1 genome occurs in the context of chromatin and is subjected to the same regulatory mechanisms that drive cellular gene expression. Much like in eukaryotic genes, the nucleosomal landscape of the HIV-1 promoter and its position within genomic chromatin are determinants of its transcriptional activity. Understanding the multilayered chromatin-mediated mechanisms that underpin HIV-1 integration and expression is of utmost importance for the development of therapeutic strategies aimed at reducing the pool of latently infected cells. In this review, we discuss the impact of chromatin structure on viral integration, transcriptional regulation and latency, and the host factors that influence HIV-1 replication by regulating chromatin organization. Finally, we describe therapeutic strategies under development to target the chromatin-HIV-1 interplay.
人类免疫缺陷病毒1型(HIV-1)建立潜伏感染的能力是研发HIV-1治愈方法的主要障碍。在潜伏感染中,具有复制能力的HIV-1前病毒整合在宿主基因组中,但保持沉默,使受感染细胞免受宿主免疫反应的作用。尽管在阐明调控HIV-1基因表达的分子因素方面取得了进展,但驱动潜伏建立和维持的机制仍未完全了解。HIV-1基因组的转录发生在染色质环境中,并受到驱动细胞基因表达的相同调控机制的影响。与真核基因非常相似,HIV-1启动子的核小体格局及其在基因组染色质中的位置是其转录活性的决定因素。了解支撑HIV-1整合和表达的多层染色质介导机制对于开发旨在减少潜伏感染细胞库的治疗策略至关重要。在本综述中,我们讨论了染色质结构对病毒整合、转录调控和潜伏的影响,以及通过调节染色质组织影响HIV-1复制的宿主因素。最后,我们描述了正在开发的针对染色质与HIV-1相互作用的治疗策略。